SHAPE Australia (ASX:SHA): Assessing Valuation After Strategic Expansion and Double-Digit Growth

SHAPE Australia (ASX:SHA) is catching the attention of investors thanks to a transformation that goes well beyond the typical paint-and-carpets office refit. The company has pushed hard into sectors like modular construction, defence, education, and health, successfully reshaping both what it builds and how markets perceive its future. With double-digit revenue and profit growth alongside major new project wins, it is no surprise the stock is starting to get more airtime in conversations about small-cap growth stories. Backing up that narrative, the share price has surged nearly 79% over the past year, showing strong upward momentum that goes hand in hand with its business achievements. Results like 14% revenue growth and significant project pipeline expansion suggest SHAPE’s shift is more than a new coat of paint; it represents a real change in earnings power and risk profile. Compared to the steady performance of a year ago, there is a buzz that the company could be entering a higher growth phase. This leads to the big question: after this run, is there still value to be found in SHAPE Australia, or has the market already priced in every bit of that future growth?

Most Popular Narrative: 14.5% Undervalued

According to the most popular narrative, SHAPE Australia is seen as undervalued, with a fair value suggesting considerable upside from its current share price. This perspective is anchored on expectations of robust future earnings growth, margin improvement, and an attractive risk-return profile based on current analyst projections and sector trends.

“SHAPE Australia's significant pipeline growth (25% YoY) is rooted in urban population expansion, non-office sector growth (health, education, defense, aged care), and continued urban densification, providing a robust tailwind for future revenue growth.

The company is leveraging sustainability and green building requirements (highlighted by Climate Active certification, Green Star projects, and new ESG management structure), positioning itself to win higher-margin, repeat business as environmental standards become mandatory. This is likely supporting net margin expansion.”

Want to know what is fueling this double-digit upside? The narrative relies on fast revenue growth, ambitious profit margin goals, and an industry premium valuation multiple that might surprise even growth investors. The real figures behind analyst optimism are worth a closer look for anyone tracking this stock’s next move.

Result: Fair Value of $5.27 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent industry competition and a shift away from traditional office space could pose challenges to SHAPE Australia's continued strong growth outlook.

Find out about the key risks to this SHAPE Australia narrative.

Another View

If we look at our DCF model, it also points to SHAPE Australia being undervalued, supporting the upside suggested by analyst forecasts. However, can two different models agree on what the future really holds?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out SHAPE Australia for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own SHAPE Australia Narrative

Keep in mind, if you see things differently or want to dig into the numbers yourself, our tools let you create your own perspective in just a few minutes. Do it your way

A great starting point for your SHAPE Australia research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

Don’t miss out on the chance to lead your portfolio with tomorrow’s winning stocks. Use Simply Wall Street’s Screener to pinpoint unique opportunities most investors overlook.

• Uncover growth potential by targeting penny stocks with strong financials. Start your search with penny stocks with strong financials now and spot high-upside names early.
• Tap into the future of medicine by following healthcare trends and finding the companies reshaping patient care through intelligent systems at healthcare AI stocks.
• Boost your income stream by seeking out dividend stocks with yields above 3%, all conveniently gathered for you with dividend stocks with yields > 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com